Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

792 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Spotlight on Drug-Induced Vasculitis.
Yaseen K, Nevares A, Tamaki H. Yaseen K, et al. Among authors: tamaki h. Curr Rheumatol Rep. 2022 Nov;24(11):323-336. doi: 10.1007/s11926-022-01088-0. Epub 2022 Sep 21. Curr Rheumatol Rep. 2022. PMID: 36129631 Review.
Eosinophilia in Rheumatologic/Vascular Disorders.
Tamaki H, Chatterjee S, Langford CA. Tamaki H, et al. Immunol Allergy Clin North Am. 2015 Aug;35(3):453-76. doi: 10.1016/j.iac.2015.05.001. Epub 2015 Jun 17. Immunol Allergy Clin North Am. 2015. PMID: 26209895 Review.
Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y).
Landewé RB, Gensler LS, Poddubnyy D, Rahman P, Hojnik M, Li X, Liu Leage S, Adams D, Carlier H, Van den Bosch F; COAST-Y study group. Landewé RB, et al. Ann Rheum Dis. 2021 Aug;80(8):1022-1030. doi: 10.1136/annrheumdis-2020-219717. Epub 2021 May 6. Ann Rheum Dis. 2021. PMID: 33958326 Free PMC article. Clinical Trial.
Blood pressure reduction with empagliflozin in Japanese patients with type 2 diabetes and cardiovascular diseases: a post-hoc sub-analysis of the placebo-controlled randomized EMBLEM trial.
Tanaka A, Shimabukuro M, Teragawa H, Yoshida H, Okada Y, Takamura T, Taguchi I, Toyoda S, Tomiyama H, Ueda S, Higashi Y, Node K; EMBLEM Investigators. Tanaka A, et al. Hypertens Res. 2024 May 24. doi: 10.1038/s41440-024-01725-4. Online ahead of print. Hypertens Res. 2024. PMID: 38789538
Atrimonas thermophila gen. nov., sp. nov., a novel anaerobic thermophilic bacterium of the phylum Atribacterota isolated from deep subsurface gas field and proposal of Atrimonadaceae fam. nov. within the class Atribacteria in the phylum Atribacterota.
Kawamoto H, Watanabe M, Mochimaru H, Nakahara N, Meng XY, Sakamoto S, Morinaga K, Katayama T, Yoshioka H, Nomura N, Tamaki H. Kawamoto H, et al. Among authors: tamaki h. Syst Appl Microbiol. 2024 May 6;47(4):126515. doi: 10.1016/j.syapm.2024.126515. Online ahead of print. Syst Appl Microbiol. 2024. PMID: 38776610 Free article.
Deficiency of β-xylosidase activity in Aspergillus luchuensis mut. kawachii IFO 4308.
Zhu E, Hiramatsu K, Inoue T, Mori K, Tashiro K, Fujita K, Karashima T, Takashita H, Okutsu K, Yoshizaki Y, Takamine K, Tamaki H, Futagami T. Zhu E, et al. Among authors: tamaki h. Biosci Biotechnol Biochem. 2024 Apr 15:zbae046. doi: 10.1093/bbb/zbae046. Online ahead of print. Biosci Biotechnol Biochem. 2024. PMID: 38621718
792 results